Andrea van Elsas
Publications by Year
Research Areas
Immunotherapy and Immune Responses, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation(1999)1,013 cited
- → Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses(2001)1,013 cited
- → bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice(1998)487 cited
- → Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity(2018)421 cited
- → APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment(2016)350 cited
- → Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine(2001)307 cited
- → CD47–signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction(2011)272 cited
- → Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition(2020)198 cited
- Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.(1996)
- → Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy(2020)106 cited